Josef Rüschoff
Impact in
- Oncology top 0.1%
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Screening and Detection
- Pathology and Forensic Medicine top 0.1%
- Genetic factors in colorectal cancer
Papers in
- Oncology 114
- HER2/EGFR in Cancer Research 48
- Colorectal Cancer Screening and Detection 24
- Colorectal Cancer Treatments and Studies 19
- Cancer Immunotherapy and Biomarkers 14
-
- Genetic factors in colorectal cancer 61
- Co-authors
- Michaela Lehle (2 shared papers)Eric Van Cutsem (2 shared papers)Julie Hill (2 shared papers)Yung‐Jue Bang (2 shared papers)Florian Lordick (6 shared papers)Lin Shen (1 shared paper)Akira Sawaki (1 shared paper)Yoon‐Koo Kang (1 shared paper)
- Journals
- Modern Pathology (12 papers)Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (11 papers)International Journal of Cancer (5 papers)The Journal of Pathology (5 papers)American Journal of Clinical Pathology (4 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Josef Rüschoff
221 papers receiving 23.3k citations
Josef Rüschoff's Hit Papers
Peers
Comparison fields: 5 of 153
- Oncology 11.6k
- Pathology and Forensic Medicine 5.3k
- Cancer Research 4.2k
- Gastroenterology 1.1k
- Pulmonary and Respiratory Medicine 5.7k
Countries citing papers authored by Josef Rüschoff
This map shows the geographic impact of Josef Rüschoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josef Rüschoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josef Rüschoff more than expected).
Fields of papers citing papers by Josef Rüschoff
This network shows the impact of papers produced by Josef Rüschoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josef Rüschoff. The network helps show where Josef Rüschoff may publish in the future.
Co-authors
The 25 scholars most cited alongside Josef Rüschoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 230 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial Hit paper breakdown → | 2010 | 5913 |
| 2 | Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer Hit paper breakdown → | 2005 | 4136 |
| 3 | Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability Hit paper breakdown → | 2004 | 2539 |
| 4 | Assessment of a HER2 scoring system for gastric cancer: results from a validation study Hit paper breakdown → | 2008 | 987 |
| 5 | Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Hit paper breakdown → | 1997 | 653 |
| 6 | HER2 testing in gastric cancer: a practical approach Hit paper breakdown → | 2012 | 505 |
| 7 | HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer Hit paper breakdown → | 2014 | 484 |
| 8 | 2010 | 407 | |
| 9 | 2016 | 305 | |
| 10 | 2013 | 246 | |
| 11 | 2003 | 234 | |
| 12 | 1999 | 222 | |
| 13 | 2004 | 195 | |
| 14 | 1993 | 182 | |
| 15 | 2005 | 171 | |
| 16 | 2014 | 160 | |
| 17 | HER2 status in non-small cell lung cancer: results from patient screening for enrollment to a phase II study of herceptin. | 2003 | 156 |
| 18 | 1998 | 153 | |
| 19 | 2005 | 153 | |
| 20 | Microsatellite instability analysis: a multicenter study for reliability and quality control. | 1997 | 140 |
About Josef Rüschoff
Josef Rüschoff is a scholar working on Oncology, Pathology and Forensic Medicine, Cancer Research, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 230 papers that have together received 24.1k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (61 papers), HER2/EGFR in Cancer Research (48 papers), Cancer Genomics and Diagnostics (30 papers), Monoclonal and Polyclonal Antibodies Research (29 papers), Colorectal Cancer Screening and Detection (24 papers), Colorectal Cancer Treatments and Studies (19 papers), Gastric Cancer Management and Outcomes (15 papers) and Cancer Immunotherapy and Biomarkers (14 papers). The work is most often cited by research in Oncology (11.6k citations), Pathology and Forensic Medicine (5.3k citations), Cancer Research (4.2k citations), Gastroenterology (1.1k citations) and Pulmonary and Respiratory Medicine (5.7k citations). Josef Rüschoff has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Michaela Lehle, Eric Van Cutsem, Julie Hill, Yung‐Jue Bang, Florian Lordick, Lin Shen, Akira Sawaki, Yoon‐Koo Kang, Andrea Feyereislova and Atsushi Ohtsu. Their work appears in journals such as Modern Pathology, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, International Journal of Cancer, The Journal of Pathology and American Journal of Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.